DEI | pharmaphorum

Friday 14 March 2025

Channels

Content type

Categories

Categories

Sort by

Order

DEI

R&D

diverse path, arrows in three directions on ground

Diversity in STEM in 2024: A reflection and a path forward

In recent years, the fields of Science, Technology, Engineering, and Mathematics (STEM) have been the cornerstone of innovation and progress.

Patients

diversity illustration

How to advance diversity, equity and inclusion in clinical t...

The principles of diversity, equity and inclusion (DEI) are now a commonplace expectation in our world, positively impacting everything, from workplaces to classrooms to hospital halls.

R&D

Embracing diversity many people linked together

Embracing diversity in psychiatry and neurology clinical tri...

There is broad recognition of the need to promote diversity and inclusion in clinical trials, with the goal of improving health equity and enhancing the validity and generalisability of stu

Patients

diversity

Action by FDA ensures trial sponsors must consider diversity

Pharma has recognised that there is a problem with diversity in clinical trials, but has so far struggled to successfully achieve real change.

Oncology

diversity in clinical trials

Building resilience in cancer trials

Clinical trials are a cornerstone of oncology research, vital for turning scientific breakthroughs into effective cancer treatments.

Sales & Marketing

PM Society DEI Interest Group Survey

Partner Content

Diversity and Inclusion Interest Group Survey

Your industry needs you for the PM Society Diversity, Equity, and Inclusion Interest Group benchmarking survey 2024.